Comparison of FDG PET/CT and CT in response assessment and prognosis of patients with extra medullary disease in acute myeloid leukemia

Conclusions: AML is usually associated with significant unidentified extra-medullary disease. PET/CT is able to identify more lesions and more metabolically progressive disease than CT alone, thus impacting management. Among semi quantitative parameters only TBR is able to differentiate between response categories.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Kumar, R., Harish, N., Sharma, A., Gupta, R. K., Sharma, A., Bakhshi, S., Patel, C., Sreedharan Thankarajan, A., Bal, C. Tags: Lymphoma / Leukemia / Myeloma Posters Source Type: research